Monkeypox for the Allergist

Price: FREE for members, $25 non-members

This 45-minute CME webinar addresses the epidemiology, diagnosis, treatment and vaccines for monkeypox. We will also look at vaccine side effects and special populations. Our experts include Drs Kathryn Convers, Sangeetha Kodoth and Niraj Patel.

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring activity for a maximum of 0.75 AMA PRA Category I Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience

Allergists, allied health and other allergy practitioners.

Learning Objectives

After completing this webinar, participants should be able to:
1) improve basic knowledge and clinical recognition of monkey pox.
2) summarize the current treatments available and the monitoring/treatment recommendations.
3) assess the monkey pox vaccine, its side effects and how it relates to special populations such as those with primary immunodeficiency and atopic dermatitis.

Additional information
Disclosure: 

Disclosure Statement
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months. The ACCME defines a “ineligible company” as companies whose primary business is producing, marketing, re-selling, or distributing health care goods or services, used by or on patients. Examples of such organizations include: 
 
•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers
  
The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.
Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.
Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All identified relevant financial relationships have been mitigated.

Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Attendance
Course opens: 
09/15/2022
Course expires: 
09/14/2025
Cost:
$25.00
Rating: 
0

Kathryn Convers, MD: Dr. Convers is an allergist-immunologist in Lakeland, FL., specializing in allergy disorders of the immune system, including food, insect and respiratory allergies, eczema, asthma, and immune deficiencies such as HIV/AIDS. Dr. Convers has no relevant financial relationships with ineligible companies to disclose.

Sangeetha Kodoth, MD: Dr. Kodoth is an allergist-immunologist in Knoxville, TN., and is affiliated with multiple hospitals in the area, including Fort Sanders Regional Medical Center and The University of Tennessee Medical Center. Dr. Kodoth has no relevant financial relationships with ineligible companies to disclose.

Niraj Patel, MD: Dr. Patel is a pediatric allergist-immunologist at Children’s Healthcare of Atlanta, GA., and specializes in primary immunodeficiency diseases and infections in immunocompromised hosts. Dr. Patel has no relevant financial relationships with ineligible companies to disclose.

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Attendance

Price

Cost:
$25.00
Please login or create an account to take this course.